Medicare's Drug-Pricing Proposal Raises Concerns Over Innovation Costs

A new drug-pricing proposal from the Centers for Medicare and Medicaid Services, despite the Trump administration's stated goal of accelerating medical innovation, is feared to carry a hidden cost by potentially hindering such advancements.